Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153346989> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2153346989 endingPage "109" @default.
- W2153346989 startingPage "108" @default.
- W2153346989 abstract "L’olmésartan appartient à la famille des antagonistes des récepteurs de l’angiotensine II, indiqué dans le traitement de l’hypertension artérielle. Des complications digestives sévères, incluant des entéropathies et des colites lymphocytaires, ont été décrites sous olmésartan.Nous rapportons deux observations d’entéropathie sévère induite par l’olmésartan, se traduisant par un syndrome de malabsorption secondaire à une atrophie villositaire. L’interruption de ce traitement a permis la disparition de l’ensemble des manifestations cliniques et la régression des anomalies biologiques.Nos observations soulignent que l’interrogatoire constitue une étape clé de la démarche diagnostique, qui a permis de retenir l’imputabilité de l’olmésartan dans l’apparition des troubles digestifs. De façon intéressante, l’accent a été mis récemment sur le fait que d’autres antagonistes des récepteurs de l’angiotensine II pourraient être responsables d’entéropathies ; des travaux complémentaires sont nécessaires pour déterminer le risque de survenue d’entéropathie sous antagonistes des récepteurs de l’angiotensine II.Olmesartan is an angiotensin II receptor blocker, used to treat arterial hypertension. Severe digestive manifestations have been associated with olmesartan, including sprue-like enteropathy and lymphocytic colitis.We report two cases of sprue-like enteropathy associated with olmesartan, leading to malabsorption syndrome related to villous atrophy. After olmesartan discontinuation, patients exhibited resolution of clinical digestive symptoms and disappearance of biochemical abnormalities.Our case reports underscore that accurate questioning is crucial in diagnostic approach, allowing to make the diagnosis of sprue-like enteropathy related to olmesartan in our patients. Interestingly, particular attention has recently been drawn to the fact that sprue-like disease may be a class effect of angiotensin II receptor blockers; further investigations are warranted to confirm these latter data." @default.
- W2153346989 created "2016-06-24" @default.
- W2153346989 creator A5035514820 @default.
- W2153346989 date "2015-02-01" @default.
- W2153346989 modified "2023-09-24" @default.
- W2153346989 title "Reporte de caso clínico: enteropatía sprue-like secundaria a uso de olmesartán" @default.
- W2153346989 cites W1602358023 @default.
- W2153346989 cites W2005398267 @default.
- W2153346989 cites W2106165182 @default.
- W2153346989 doi "https://doi.org/10.1016/j.gastrohep.2014.05.006" @default.
- W2153346989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24958550" @default.
- W2153346989 hasPublicationYear "2015" @default.
- W2153346989 type Work @default.
- W2153346989 sameAs 2153346989 @default.
- W2153346989 citedByCount "8" @default.
- W2153346989 countsByYear W21533469892014 @default.
- W2153346989 countsByYear W21533469892015 @default.
- W2153346989 countsByYear W21533469892019 @default.
- W2153346989 countsByYear W21533469892020 @default.
- W2153346989 crossrefType "journal-article" @default.
- W2153346989 hasAuthorship W2153346989A5035514820 @default.
- W2153346989 hasConcept C126322002 @default.
- W2153346989 hasConcept C134018914 @default.
- W2153346989 hasConcept C2778426112 @default.
- W2153346989 hasConcept C2778776759 @default.
- W2153346989 hasConcept C2779134260 @default.
- W2153346989 hasConcept C2779766728 @default.
- W2153346989 hasConcept C2780349322 @default.
- W2153346989 hasConcept C2780439177 @default.
- W2153346989 hasConcept C2780566776 @default.
- W2153346989 hasConcept C29456083 @default.
- W2153346989 hasConcept C3019900444 @default.
- W2153346989 hasConcept C54355233 @default.
- W2153346989 hasConcept C71924100 @default.
- W2153346989 hasConcept C84393581 @default.
- W2153346989 hasConcept C86803240 @default.
- W2153346989 hasConcept C90924648 @default.
- W2153346989 hasConceptScore W2153346989C126322002 @default.
- W2153346989 hasConceptScore W2153346989C134018914 @default.
- W2153346989 hasConceptScore W2153346989C2778426112 @default.
- W2153346989 hasConceptScore W2153346989C2778776759 @default.
- W2153346989 hasConceptScore W2153346989C2779134260 @default.
- W2153346989 hasConceptScore W2153346989C2779766728 @default.
- W2153346989 hasConceptScore W2153346989C2780349322 @default.
- W2153346989 hasConceptScore W2153346989C2780439177 @default.
- W2153346989 hasConceptScore W2153346989C2780566776 @default.
- W2153346989 hasConceptScore W2153346989C29456083 @default.
- W2153346989 hasConceptScore W2153346989C3019900444 @default.
- W2153346989 hasConceptScore W2153346989C54355233 @default.
- W2153346989 hasConceptScore W2153346989C71924100 @default.
- W2153346989 hasConceptScore W2153346989C84393581 @default.
- W2153346989 hasConceptScore W2153346989C86803240 @default.
- W2153346989 hasConceptScore W2153346989C90924648 @default.
- W2153346989 hasIssue "2" @default.
- W2153346989 hasLocation W21533469891 @default.
- W2153346989 hasLocation W21533469892 @default.
- W2153346989 hasOpenAccess W2153346989 @default.
- W2153346989 hasPrimaryLocation W21533469891 @default.
- W2153346989 hasRelatedWork W2059434222 @default.
- W2153346989 hasRelatedWork W2160639867 @default.
- W2153346989 hasRelatedWork W2290927540 @default.
- W2153346989 hasRelatedWork W2411047859 @default.
- W2153346989 hasRelatedWork W2566930343 @default.
- W2153346989 hasRelatedWork W2765476131 @default.
- W2153346989 hasRelatedWork W2893939742 @default.
- W2153346989 hasRelatedWork W4246102654 @default.
- W2153346989 hasRelatedWork W4283080050 @default.
- W2153346989 hasRelatedWork W2505568884 @default.
- W2153346989 hasVolume "38" @default.
- W2153346989 isParatext "false" @default.
- W2153346989 isRetracted "false" @default.
- W2153346989 magId "2153346989" @default.
- W2153346989 workType "article" @default.